Class information for:
Level 1: COST EFFECTIVENESS ANALYSIS//BRIGHAM WOMENS FAULKNER NEUROL//OPTIMAL TRIAL DESIGN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4800 1651 31.0 60%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1443 7316 EQ 5D//HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COST EFFECTIVENESS ANALYSIS Author keyword 19 10% 10% 173
2 BRIGHAM WOMENS FAULKNER NEUROL Address 11 100% 0% 6
3 OPTIMAL TRIAL DESIGN Author keyword 11 100% 0% 6
4 PROBABILISTIC SENSITIVITY ANALYSIS Author keyword 9 34% 1% 22
5 BIOMEDICAL RESEARCH METHODS Author keyword 9 83% 0% 5
6 COST EFFECTIVENESS ACCEPTABILITY CURVE Author keyword 9 83% 0% 5
7 NET HEALTH BENEFIT Author keyword 9 83% 0% 5
8 COST EFFECTIVENESS RATIOS Author keyword 9 67% 0% 8
9 VALUE OF INFORMATION Author keyword 9 13% 4% 61
10 INCREMENTAL NET BENEFIT Author keyword 8 70% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 COST EFFECTIVENESS ANALYSIS 19 10% 10% 173 Search COST+EFFECTIVENESS+ANALYSIS Search COST+EFFECTIVENESS+ANALYSIS
2 OPTIMAL TRIAL DESIGN 11 100% 0% 6 Search OPTIMAL+TRIAL+DESIGN Search OPTIMAL+TRIAL+DESIGN
3 PROBABILISTIC SENSITIVITY ANALYSIS 9 34% 1% 22 Search PROBABILISTIC+SENSITIVITY+ANALYSIS Search PROBABILISTIC+SENSITIVITY+ANALYSIS
4 BIOMEDICAL RESEARCH METHODS 9 83% 0% 5 Search BIOMEDICAL+RESEARCH+METHODS Search BIOMEDICAL+RESEARCH+METHODS
5 COST EFFECTIVENESS ACCEPTABILITY CURVE 9 83% 0% 5 Search COST+EFFECTIVENESS+ACCEPTABILITY+CURVE Search COST+EFFECTIVENESS+ACCEPTABILITY+CURVE
6 NET HEALTH BENEFIT 9 83% 0% 5 Search NET+HEALTH+BENEFIT Search NET+HEALTH+BENEFIT
7 COST EFFECTIVENESS RATIOS 9 67% 0% 8 Search COST+EFFECTIVENESS+RATIOS Search COST+EFFECTIVENESS+RATIOS
8 VALUE OF INFORMATION 9 13% 4% 61 Search VALUE+OF+INFORMATION Search VALUE+OF+INFORMATION
9 INCREMENTAL NET BENEFIT 8 70% 0% 7 Search INCREMENTAL+NET+BENEFIT Search INCREMENTAL+NET+BENEFIT
10 GUIDELINES AS TOPIC STANDARDS 8 100% 0% 5 Search GUIDELINES+AS+TOPIC+STANDARDS Search GUIDELINES+AS+TOPIC+STANDARDS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EFFECTIVENESS RATIOS 111 76% 5% 77
2 MULTINATIONAL CLINICAL TRIALS 30 79% 1% 19
3 EXPECTED VALUE 25 31% 4% 67
4 COST EFFECTIVENESS MODELS 19 68% 1% 17
5 PROBABILISTIC SENSITIVITY ANALYSIS 17 55% 1% 21
6 HEALTH CARE TECHNOLOGIES 15 62% 1% 16
7 COST EFFECTIVENESS RATIOS 14 65% 1% 13
8 EFFECTIVENESS ACCEPTABILITY CURVES 12 27% 2% 39
9 UTILITY ANALYSES 11 54% 1% 14
10 ALONGSIDE 10 46% 1% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Good practice guidelines for decision-analytic modelling in health technology assessment - A review and consolidation of quality assessment 2006 141 13 92%
Standardisation of costs - The Dutch manual for costing in economic evaluations 2002 198 16 75%
Thinking outside the box: Recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies 2002 165 41 63%
Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods 2002 88 20 85%
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report 2009 27 79 65%
Sensitivity Analysis in Cost-Effectiveness Studies From Guidelines to Practice 2011 14 36 72%
Review of guidelines for good practice in decision-analytic modelling in health technology assessment 2004 143 32 50%
A Systematic and Critical Review of the Evolving Methods and Applications of Value of Information in Academia and Practice 2013 9 118 62%
Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies 2003 50 22 86%
Cost-effectiveness analyses of vaccination programmes - A focused review of modelling approaches 2008 61 78 38%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BRIGHAM WOMENS FAULKNER NEUROL 11 100% 0.4% 6
2 EVALUAT VALUE RISK HLTH 8 24% 1.6% 27
3 NICE DECIS SUPPORT UNIT 4 67% 0.2% 4
4 HLTH ECON EVALUAT TECHNOL ASSESSMENT 3 100% 0.2% 3
5 PROGRAM ECON EVALUAT MED TECHNOL 3 26% 0.6% 10
6 PUBL HLTH DECIS MODELLING HLTH TECHNOL ASSESS 2 67% 0.1% 2
7 PROGRAM ASSESSMENT RADIOL TECHNOL 2 23% 0.4% 7
8 INTERNAL MED OUTPATIENT 2 43% 0.2% 3
9 PROGRAM POPULAT HLTH SCI 2 19% 0.4% 7
10 STAT SCI EPIDEMIOL 1 25% 0.3% 5

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000216168 Q TWIST//HEALTH ECONOMETRICS//LOG MODELS
2 0.0000154744 HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//COVERAGE WITH EVIDENCE DEVELOPMENT
3 0.0000151771 IST MED INTERNA VASCOLARE//AALENS MODEL//ADJUSTED SURVIVAL
4 0.0000108846 FRICTION COSTS//PRODUCTIVITY COSTS//COST OF SMOKING
5 0.0000087974 PRIORITY SETTING//ACCOUNTABILITY FOR REASONABLENESS//RATIONING
6 0.0000087705 EQ 5D//SF 6D//TIME TRADE OFF
7 0.0000083005 FORMULARY SYSTEM//FORMULARIES//PHARMACY AND THERAPEUTICS COMMITTEE
8 0.0000079989 SOCIAL AND ADMINISTRATIVE SCIENCES//APACHE II SYSTEM//GLOBAL OUTCOMES GRP
9 0.0000071393 DEALE//ORAL CASE PRESENTATIONS//SHERLOCK HOLMES
10 0.0000065451 MRC TRIAL//ABORAT PREVENT TREATMENT CARDIOVASC DIS//CLIN EPIDEMIOL HLTH CARE PROGRAM MED